All Stories

  1. Adjuvant immunotherapy in resected early non-small cell lung cancer—battle lost, hopefully not the war!
  2. Treatment options for isolated locoregional recurrences of nonsmall cell lung cancer after surgery: yes, radiation therapy too!
  3. Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database
  4. Surgery for Stage IIIA Non–Small-cell Lung Cancer: Lack of Predictive and Prognostic Factors Identifying Any Subgroup of Patients Benefiting From It
  5. Lung Cancer
  6. The Trimodality Treatment Approach in Stage III/pN2 Non–Small Cell Lung Cancer
  7. Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer
  8. No Role For Trimodality Therapy and Consolidation Chemotherapy Compared With Concurrent Radiochemotherapy Alone in Stage III Non-Small-Cell Lung Cancer
  9. Androgen receptor status is highly conserved during tumor progression of breast cancer
  10. Metal-enhanced radiotherapy: Gold nanoparticles and beyond
  11. Outcome of Proximal Esophageal Cancer After Definitive Combined Chemoradiation: A Multicenter Retrospective Study
  12. Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov Database
  13. Abstract 5173: Androgen receptor status is highly conserved during tumor progression of breast cancer
  14. Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry
  15. In Regard to Lao et al
  16. High tumor budding stratifies breast cancer with metastatic properties
  17. A Call for Careful Interpretation of Outcome of Nonsurgical Approach in Clinical Stage IIIa Non-Small Cell Lung Cancer in the National Cancer Database
  18. Analysis of Clinical Trials in Radiation Oncology: A Systematic Characterization of the Clinicaltrials.gov Database
  19. Is Molecular Remission as Detected by 18F-FDG PET/CT and Regression Grade After Neoadjuvant Treatment in the Primary Tumor and the Involved Mediastinal Lymph Nodes a Prognostic Factor in Patients With NSCLC Stage III?
  20. Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer
  21. IMRT with 18FDG-PET\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer
  22. Late toxicity and five year outcomes after high-dose-rate brachytherapy as a monotherapy for localized prostate cancer
  23. PO-0734: Dosimetric parameters of escalated dose radiotherapy in nodal positive cervical cancer patients
  24. Clinically Significant Bleeding in Incurable Cancer Patients: Effectiveness of Hemostatic Radiation Therapy
  25. A Rare Case of a Large Spinal Meningioma with Mediastinal Extension and Malignant Behavior Classified Histologically as Benign
  26. PD-0303 DOSE ESCALATION IN LOCO-REGIONALLY ADVANCED CERVICAL CANCER USING INTENSITY MODULATED RADIOTHERAPY
  27. 303 WHAT IS THE ROLE OF 99MTC-MAA SPECT/CT FOR RADIATION TREATMENT PLANING IN THORACIC TUMORS USING VMAT (RAPIDARC)?
  28. Clinically significant bleeding in incurable cancer patients: effectiveness of hemostatic radiotherapy
  29. 610 poster ACCELERATED PARTIAL BREAST IRRADIATION: A DOSIMETRIC COMPARISON OF PERI- AND POSTOPERATIVE IMPLANTS
  30. 1311 POSTER Adjuvant radiotherapy of the cervical carcinoma in elderly patients